<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1315a" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1315a/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1315a/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1315a"><akn:num>1315a</akn:num><akn:heading>Center for Medicare and Medicaid Innovation</akn:heading><akn:content><akn:p>§ 1315a. Center for Medicare and Medicaid Innovation(a) Center for Medicare and Medicaid Innovation established(1) In generalThere is created within the Centers for Medicare &amp; Medicaid Services a Center for Medicare and Medicaid Innovation (in this section referred to as the “CMI”) to carry out the duties described in this section. The purpose of the CMI is to test innovative payment and service delivery models to reduce program expenditures under the applicable subchapters while preserving or enhancing the quality of care furnished to individuals under such subchapters. In selecting such models, the Secretary shall give preference to models that also improve the coordination, quality, and efficiency of health care services furnished to applicable individuals defined in paragraph (4)(A).


(2) DeadlineThe Secretary shall ensure that the CMI is carrying out the duties described in this section by not later than January 1, 2011.


(3) ConsultationIn carrying out the duties under this section, the CMI shall consult representatives of relevant Federal agencies, and clinical and analytical experts with expertise in medicine and health care management. The CMI shall use open door forums or other mechanisms to seek input from interested parties.


(4) DefinitionsIn this section:(A) Applicable individualThe term “applicable individual” means—(i) an individual who is entitled to, or enrolled for, benefits under part A of subchapter XVIII or enrolled for benefits under part B of such subchapter;

(ii) an individual who is eligible for medical assistance under subchapter XIX, under a State plan or waiver; or

(iii) an individual who meets the criteria of both clauses (i) and (ii).


(B) Applicable subchapterThe term “applicable subchapter” means subchapter XVIII, subchapter XIX, or both.



(5) Testing within certain geographic areasFor purposes of testing payment and service delivery models under this section, the Secretary may elect to limit testing of a model to certain geo</akn:p></akn:content><akn:subsection eId="subsec_1315a_a"><akn:num>(a)</akn:num><akn:heading>Center for Medicare and Medicaid Innovation established</akn:heading><akn:content><akn:p>(a) Center for Medicare and Medicaid Innovation established</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_b"><akn:num>(b)</akn:num><akn:heading>Testing of models (phase I)</akn:heading><akn:content><akn:p>(b) Testing of models (phase I)</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_c"><akn:num>(c)</akn:num><akn:heading>Expansion of models (phase II)</akn:heading><akn:content><akn:p>(c) Expansion of models (phase II) Taking into account the evaluation under subsection (b)(4), the Secretary may, through rulemaking, expand (including implementation on a nationwide basis) the duration and the scope of a model that is being tested under subsection (b) or a demonstration project under section 1395cc–3 of this title, to the extent determined appropriate by the Secretary, if— In determining which models or demonstration projects to expand under the preceding sentence, the Secretary shall focus on models and demonstration projects that improve the quality of patient care and reduce spending.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_d"><akn:num>(d)</akn:num><akn:heading>Implementation</akn:heading><akn:content><akn:p>(d) Implementation</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_e"><akn:num>(e)</akn:num><akn:heading>Application to CHIP</akn:heading><akn:content><akn:p>(e) Application to CHIP The Center may carry out activities under this section with respect to subchapter XXI in the same manner as provided under this section with respect to the program under the applicable subchapters.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_f"><akn:num>(f)</akn:num><akn:heading>Funding</akn:heading><akn:content><akn:p>(f) Funding</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1315a_g"><akn:num>(g)</akn:num><akn:heading>Report to Congress</akn:heading><akn:content><akn:p>(g) Report to Congress Beginning in 2012, and not less than once every other year thereafter, the Secretary shall submit to Congress a report on activities under this section. Each such report shall describe the models tested under subsection (b), including the number of individuals described in subsection (a)(4)(A)(i) and of individuals described in subsection (a)(4)(A)(ii) participating in such models and payments made under applicable subchapters for services on behalf of such individuals, any models chosen for expansion under subsection (c), and the results from evaluations under subsection (b)(4). In addition, each such report shall provide such recommendations as the Secretary determines are appropriate for legislative action to facilitate the development and expansion of successful payment models.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>